Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers [Phase 1]
Phase 1 safety study update for PF-08046044/SGN-35C in adults with advanced cancers; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. [Phase 1, Phase 2]
This document describes a Phase 1/Phase 2 clinical trial evaluating AZD3470 as a monotherapy or in combination with other anticancer agents …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and in combination with ipilimumab, nivolumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers [Phase 2]
This Phase 2 clinical trial update evaluates the combination of talimogene laherparepvec (T-VEC) and nivolumab for patients with refractory …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma [Phase 1]
A Phase 1 clinical trial is evaluating intravenous vesicular stomatitis virus in patients with peripheral T-cell lymphoma and related condit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]
Phase 1 trial evaluating an anti-CD30 bispecific antibody (AATC) in relapsed/refractory CD30-positive hematologic malignancies; currently re…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) [Phase 2]
A Phase 2 trial evaluating nivolumab in pediatric and adult patients with relapsed/refractory ALK-positive anaplastic large cell lymphoma, a…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: BV-CHP Real-life and Biological Evidences in Patients With sALCL
This trial update from Fondazione Italiana Linfomi- ETS describes real-life and biological evidence regarding the BV-CHP regimen (brentuxima…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Crizotinib Continuation Clinical Study [Phase 4]
A Phase 4 continuation study of crizotinib sponsored by Pfizer is currently active but not recruiting. The study investigates crizotinib in …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL [Phase 3]
A Phase 3 clinical trial (CCCG-ALCL-2020) in Chinese children and adolescents with newly diagnosed high-risk anaplastic large cell lymphoma …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) [Phase 1]
A Phase 1 clinical trial is evaluating CCR4-directed CAR T cells in CCR4-expressing mature T-cell malignancies, including peripheral T-cell …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency [NA]
A Mayo Clinic-sponsored clinical trial evaluates cholecalciferol (vitamin D3) for improving survival in patients with newly diagnosed cancer…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers [Phase 2, Phase 3]
The DETERMINE trial treatment arm 01 is evaluating Alectinib in adult, paediatric and teenage/young adult patients with ALK-positive cancers…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL [Phase 2]
Phase 2 trial update for chemoimmunotherapy in relapsed/refractory ALK-positive anaplastic large cell lymphoma; the study is currently activ…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in …
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
A completed clinical trial evaluated blood markers of reproductive hormones to assess ovarian reserve in younger patients with newly diagnos…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation
A completed observational study describing treatment patterns and disease control in participants with Hodgkin lymphoma and anaplastic large…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating LCAR-HL30 in adults with relapsed or refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma is…
-
CLINICAL_TRIALS research · 2019-10-21Clinical Trial Update: Ceritinib Rare Indications Study in ALK+ Tumors [Phase 2]
Phase 2 trial update for ceritinib in ALK-altered tumors including anaplastic large cell lymphoma and related conditions; study terminated w…
-
CLINICAL_TRIALS research · 2018-03-15Clinical Trial Update: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study [Phase 2]
Multicentre Phase II trial comparing CHOP versus GEM-P as first-line therapy for various peripheral T-cell lymphomas; current study status i…
-
CLINICAL_TRIALS research · 2015-09-25Clinical Trial Update: Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma [NA]
This clinical trial update describes a study evaluating combination chemotherapy followed by stem cell transplant for young patients with pr…